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PURPOSE. To evaluate acquired color vision deficiency in glaucoma by using the Rabin cone
contrast test (RCCT).
METHODS. Twenty-seven eyes of 27 patients with glaucoma (glaucoma group) and 27 eyes of
27 normal subjects (control group) were included in this study. Long (L), medium (M), and
short (S) CCT scores (L CCTs, M CCTs, and S CCTs, respectively) were measured using the
RCCT in both groups. Visual field examinations were performed with Humphrey automated
perimetry using the Swedish interactive thresholding algorithm 30-2, and the mean deviation
(MD) was evaluated. The macular ganglion cell/inner plexiform layer (GCIPL) thickness was
measured using high-definition optical coherence tomography in the glaucoma group.
RESULTS. The mean M CCTs and S CCTs in the glaucoma group were significantly lower (P <
0.05 for both comparisons) than in the control group (M CCTs, 80.7 6 16.8 vs. 91.9 6 8.22; S
CCTs, 83.9 6 19.5 vs. 97.4 6 3.77, respectively); the L CCTs did not differ significantly (P ¼
0.065) from those of the controls (91.8 6 12.8 vs. 97.4 6 3.50, respectively). The M CCTs
and S CCTs were correlated significantly with those of MD (M CCTs, r ¼ 0.47; S CCTs, r ¼
0.44; P < 0.05 for both comparisons) and GCIPL thickness (M CCTs, r ¼ 0.70; P < 0.0001; S
CCTs, r ¼ 0.57; P < 0.01).
CONCLUSIONS. The chromatic discrimination thresholds measured by RCCT in the glaucoma
group were significantly different from those measured in the control group and were
correlated with the MD and GCIPL thickness. The RCCT may be useful for evaluating acquired
color vision deficiency in glaucoma and may help advance current understanding of the
pathophysiology of glaucomatous damage.
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Color vision deficiency in glaucoma was first described in1883.1 Blue-yellow deficiencies generally are associated
with early glaucoma, and red-green deficiencies generally are
associated with advanced glaucoma.2–6 However, it is difficult
to measure or quantify acquired color vision deficiency, and
color tests performed with standardized color test charts such
as the pseudoisochromatic plates or panel D-15 frequently
characterize it as combined or nonspecific color vision
deficiency.7
Recent investigations of chromatic discrimination using
computer-generated color tests have shown that color contrast
thresholds are elevated in patients with glaucoma.8–10 In these
tests, the subject is asked to report the presence of a color
target such as a spot, bar, or grating on a background of a
different color. Regan et al.11 designed a sophisticated
computerized color vision test known as the Cambridge Colour
Test. The stimulus arrays resemble the plates of a traditional
pseudoisochromatic test, such as those of the Ishihara test. The
target is C shaped, differing in chromaticity from the
background. This test has been used to evaluate acquired color
vision deficiency.12–15 Another current computerized test is the
Color Assessment Test developed by Birch et al.,16 which is
being used in occupational environments. This test is based on
a spatiotemporal luminance masking technique devised by
Birch et al.16 In this technique, part of a uniform background is
formed by spatially discrete elements that are equal in time-
averaged luminance with respect to the background. During
the stimulus presentation, each element scintillates while its
luminance varies. These two tests are capable of quantifying
the degree of color vision loss by use of color thresholds.
Rabin et al.17 developed a new computer-based, cone-specific
(L, M, S) contrast sensitivity test. The Rabin cone contrast test
(RCCT) uses a randomized series of red, green, and blue letters
visible to a single cone type (long [L], medium [M], short [S]) in
decreasing steps of contrast to measure the threshold for letter
recognition. The RCCT, which provides numeric scores of color
vision and identifies the type and severity of color vision
deficiency, can be completed in only 6 minutes. The RCCToffers
an intuitive, robust index of color vision that accurately detects
the type of color vision deficiency. The rapid, threshold letter
recognition task is well suited for clinical application. The authors
reported that it has sensitivity and specificity comparable to those
of anomaloscope test results for hereditary color vision deficiency
detection and categorization. We hypothesized that the RCCT
may also be useful to evaluate acquired color vision deficiency in
glaucoma, and we used the test to evaluate color vision
deficiencies in patients with glaucoma.
METHODS
The current study included 27 patients with glaucoma
(glaucoma group) and 27 normal volunteers with healthy eyes
(control group) who were evaluated in the Department of
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Ophthalmology, Shiga University Medical Science Hospital.
Examinations with Ishihara pseudoisochromatic plates (Kane-
hara-Shuppan Co. Ltd., Tokyo, Japan) and standard pseudoiso-
chromatic plates part 1 (Igaku-Shoin, Tokyo, Japan) were
performed to exclude patients with congenital color vision
deficiency.
The patients with glaucoma underwent a comprehensive
ophthalmic examination that included a medical history review,
measurement of the best-corrected visual acuity (BCVA)
determined with Landolt C charts, measurement of intraocular
pressure (IOP), slit-lamp examination, gonioscopy, and fundus
examination. Visual field examinations were performed with
Humphrey automated perimetry (Humphrey field analyzer
using a 30-2 grid and the Swedish interactive threshold
algorithm [Carl Zeiss Meditec, Dublin, CA, USA]). The inclusion
criteria for patients with glaucoma were a BCVA of 20/20 or
better, a refractive error of 10.00 diopters or less, an open
angle on gonioscopic examination, characteristic glaucomatous
structural changes, and glaucomatous visual field defects with
or without an elevated IOP. The criteria for the glaucomatous
visual field defects included glaucoma hemifield test results
outside the normal limits, pattern standard deviation with a P
value of <5% or a cluster of fewer than three points in the
pattern deviation plot in one hemifield (superior or inferior)
with a P < 5%, one of which must have a P < 1%.18 If both eyes
of a patient had glaucoma, the eye with the better visual field
was included in this study. If a patient had one glaucomatous
eye, the glaucomatous eye was included in this study. Macular
scanning was obtained using high-definition optical coherence
tomography (OCT; Cirrus; Carl Zeiss Meditec). The ganglion
cell analysis algorithm was used to detect the macular ganglion
cell-inner plexiform layer (GCIPL) and measure the average
thickness of the overall GCIPL.
The eyes of the volunteers were categorized as normal if
they had a BCVA of 20/20 or better, a refractive error of10.00
diopters or less, an IOP of 21 mm Hg or less, and an optic disc
head that appeared normal. Only one eye of each patient was
randomly selected. Subjects with normal eyes did not undergo
visual field examinations and OCT examinations.
The exclusion criteria for both groups were congenital
color vision deficiency, cataract with nuclear sclerosis exceed-
ing 2þ (according to the Emery-Little system19), evidence of
vitreoretinal disease, history of any ophthalmic surgery,
systemic disease that might affect visual function (e.g.,
diabetes, hypertension, anemia, cerebrovascular disease, or
renal disease), or a history of dementia.
Rabin Cone Contrast Test
The L, M, and S cone contrast test scores (L CCTs, M CCTs, and
S CCTs, respectively) were measured using the commercially
available Rabin Cone Contrast Test (Provideo CCT Plus system;
Innova Systems, Burr Ridge, IL, USA) in both study groups. The
RCCT measures the contrast threshold levels of red, green, and
blue cones. The RCCT presents a randomized series of red,
green, and blue letters visible to a single cone type (L, M, or S).
A letter of one color (D, E, F, H, N, P, R, U, V, Z in Arial bold font;
L and M cones, 20/300; S cone, 20/400) is presented in the
center of the display (Inspiron One 2330 computer; Dell,
Round Rock, TX, USA). The letter and background have the
same luminance and differ only in chromaticity. Due to
overlapping cone functions, it is impossible to limit stimulation
to a single cone type, but by maintaining equal stimulation in
the letter and background (undetectable) for two cone types
while systematically stimulating the third, the letter is
detectable only by a single class of cones. The subject
identifies the letters aloud. The letters decrease from a clearly
visible cone contrast to a threshold level (L and M cone, 27.5%–
1%; S cone, 173%–7%). The RCCT is conducted monocularly in
a dark room at 36 inches; distance correction (þ0.75 diopter) is
worn if improved visibility of the letters is reported. The cone
contrast sensitivity scores are normalized to a 100-point scale
(passing scores are 75 points or more).
Statistical Analysis
All statistical analyses were performed using Prism 6 software
(GraphPad, Inc., La Jolla, CA, USA). The Mann-Whitney U test
was used to compare the baseline characteristics between the
2 groups and the RCCT scores between the 2 groups. The
Fisher exact test was used to compare the number of eyes with
failing scores (<75) between the two groups. The Spearman
rank correlation test was used to analyze the correlation
between the RCCT scores and mean deviation (MD) or GCIPL
thickness in the glaucoma group. A P value of <0.05 was
considered significant.
The institutional review board of Shiga University of
Medical Science approved the review of patient data for this
study. All participants provided written informed consent and
the study adhered to the tenets of the Declaration of Helsinki.
RESULTS
No patient failed color vision testing with the Ishihara
pseudoisochromatic plates and standard pseudoisochromatic
plates part 1 in the both glaucoma and control groups. The
mean 6 SD patient age was 63.7 6 9.5 years in the glaucoma
group and 59.3 6 11.0 years in the control group. Table 1
shows the patient demographics in the two groups. There
were no significant differences between the two groups in
terms of age, sex, BCVA, IOP, or refractive error. The numbers
of eyes with failing scores (<75) are shown in Table 2. Four
eyes (15%) in the glaucoma group and no eyes in the control
group had reduced L CCTs, a between-group difference that
did not reach significance (P¼ 0.11). However, 11 eyes (41%)
in the glaucoma group and 1 eye (4%) in the control group had
reduced M CCTs, and 9 eyes (33%) in the glaucoma group and
1 eye (4%) in the control group had reduced S CCTs. Both
between-group differences were significant (P < 0.005).
The mean L CCTs tended to be lower in the glaucoma group
than in the control group (L CCTs, 91.86 12.8 vs. 97.46 3.50,
respectively), but the differences did not reach significance
(P¼ 0.065). The mean M and S CCTs were significantly lower
(M CCTs, 80.7 6 16.8 vs. 91.9 6 8.22, respectively, P < 0.05;
TABLE 1. Demographics of the Study Groups
Characteristic
Glaucoma
Group
Control
Group
Men/women 17/10 17/10
Mean age 6 SD, y 63.7 6 9.5 59.3 6 11.0
Mean BCVA 6 SD, logMar 0.13 6 0.06 0.10 6 0.06
Mean IOP 6 SD, mm Hg 14.3 6 3.6 13.7 6 2.9
Mean refractive error 6 SD 2.84 6 3.16 2.63 6 3.01
BCVA, best corrected visual acuity; logMar, logarithm of the
minimum angle of resolution; IOP, intraocular pressure; SD, standard
deviation.
TABLE 2. Number of Eyes With a Failing Score (<75)
Group L CCT M CCT S CCT
Glaucoma/total 4/27 11/27 9/27
Control/total 0/27 1/27 1/27
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S CCTs, 83.9 6 19.5 vs. 97.4 6 3.77, respectively, P < 0.05) in
the glaucoma group than in the control group (Fig. 1). In the
glaucoma group, the correlations were statistically significant
between L CCTs and M CCTs (r¼ 0.42, P < 0.05) and M CCTs
and between L CCTs and S CCTs (r¼ 0.48, P < 0.05) but not
between L CCTs and S CCTs (r¼ 0.216, P¼ 0.28).
The mean MD in the glaucoma group was5.76 4.7 decibels
(dB) (range, 0.48 to 13.77 dB). The M and S CCTs were
correlated significantlywith theMD(MCCTs, r¼0.47,P< 0.05; S
CCTs, r ¼ 0.44, P < 0.05). The mean GCIPL thickness in the
glaucoma group (68.9 6 8.31 lm [range, 56–83 lm]) was
significantly correlated with the M and S CCTs (M CCTs, r¼0.70,
P< 0.0001; SCCTs, r¼0.57,P< 0.01).However, the LCCTswere
not correlated significantly with the MD or GCIPL (MD, r¼0.037,
P¼ 0.85; GCIPL, r¼ 0.27, P¼ 0.17) (Figs. 2, 3).
DISCUSSION
In the current study, the mean M and S CCTs in the glaucoma
group were significantly lower (P < 0.05 for both comparisons)
than in the control group. The mean L CCTs in the glaucoma
group tended to be lower than in the control group, although the
differences did not reach significance (P¼ 0.065). Loss of blue-
yellow sensitivity is the most common form of acquired color
vision deficiency in patients with glaucoma.2–6 A few previous
studies have reported selective loss of red-green sensitivity.
Greenstein et al.20 studied foveal chromatic sensitivity in
glaucoma by using flicker photometry and reported similar
sensitivity losses for both the red-green and blue-yellow
opponent systems. Alvarez et al.21 reported selective loss of
red-green chromatic sensitivity in glaucoma. Castelo-Branco15
examined acquired color vision deficiency in glaucoma by using
the Cambridge color test and reported the presence of macular
function damage in the both blue-yellow and red-green opponent
pathways. Rabin22 used the RCCT to quantify the threshold of
cone-specific contrast of acquired color vision deficiency under
various ocular conditions and in various diseases and reported
that M cone contrast sensitivity was more susceptible than L and
S cone sensitivity. Our current results are consistent with results
of these reports. Foveal chromatic sensitivity loss may not be
restricted to the blue-yellow opponent pathway but may also
include the red-green opponent pathway. In addition, the
current study shows statistically significant correlations between
L CCTs and M CCTs (r¼0.42, P< 0.05) and M CCTs and S CCTs
(r¼0.48, P< 0.05) in eyes affected by glaucoma. Using the Color
Assessment Test by Birch et al.,16 Rauscher et al.23 found that red-
green loss is almost as common as blue-yellow loss in glaucoma
patients. Our current results also imply a correlation between
red-green and blue-yellow loss in glaucoma patients.
In the current study, 11 eyes (41%) and 9 eyes (33%) in the
glaucoma group had failing M CCTs and S CCTs, respectively.
The failing scores of our study were relatively small. Measuring
foveal color contrast sensitivity, Falcao-Reis et al.24 found color
contrast sensitivity thresholds of more than 2 SD above the
normal mean in 69% of glaucoma patients and 32% of ocular
hypertensive patients. Color contrast thresholds overlapped
among those of normal subjects, ocular hypertension patients,
and glaucoma patients. An appropriate cutoff point to separate
normal from glaucoma patients would therefore be difficult to
find. In addition, our RCCT results reflect foveal performance,
whereas early glaucomatous damage occurs in the peripheral
part of the vision field.25 Using a peripheral color contrast test
of their own devising, Yu et al.10 showed that all glaucoma
patients had more than 2 SDs above the normal mean
threshold. Thus, the peripheral loss of color vision in glaucoma
may well be greater than the foveal loss.
The current study shows a significant decrement in M and S
but not L CCTs in the glaucoma group. The healthy human
crystalline lens gradually becomes yellow as part of the normal
aging process. This yellowing may preferentially affect the blue-
yellow losses. However, there were no significant differences in
age between the two groups in this study. Moreover, patients
with severe cataract (nuclear sclerosis exceeding 2þ, BCVA
<20/20) were excluded from this study. The current results
show that pre-receptor spectral filters are unlikely to have a
significant effect. Another possible explanation may be related
to cone numbers. Listed in order of abundance from most to
least, these are L, M, and S cones (7%). If we posit that inputs
from cones are balanced by gain mechanisms,26 damage to the
FIGURE 1. RCCT results for each cone are compared between those of
the glaucoma group () and the control group (*). The mean M and S
CCTs in the glaucoma group are significantly lower (P < 0.05 for both
comparisons) than those in the control group (M CCTs¼ 80.7 6 16.8,
vs. 91.9 6 8.22, respectively; S CCTs ¼ 83.9 6 19.5 vs. 97.4 6 3.77,
respectively).
FIGURE 2. Correlation between CCT scores and MD in the glaucoma group is shown. (A) Correlation between L CCTs and MD. (B) Correlation
between M CCTs and MD. (C) Correlation between S CCTs and MD. Correlations were determined by the Spearman rank correlation test.
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gain mechanisms may affect the pathways in a manner inversely
proportional to the size of the cone population. Fewer cones
may increase vulnerability to pathology.
It has been suggested that there are individual variations of
spectral sensitivity of L and M cones in normal trichromacy.
One source of variation is the Ser180Ala polymorphism in the L
cone pigment gene.27 Another source of variation is the
existence of several types of L/M hybrid cone photopig-
ments.28,29 In addition, it is becoming increasingly appreciated
that the ratio of L to M cones varies widely in the retina.30,31
The variability of the photopigments with different spectral
properties and the variability of L-to-M ratio in normal
trichromacy may reflect the failure to isolate single cone
responses. However, several studies have reported that
individuals do not seem to have correspondingly different
color vision.32,33 Rabin et al.17 (who developed the RCCT)
reported that the RCCT has almost 100% specificity for
confirming normal color vision and that the RCCT score was
rarely outside normal limits, despite its relatively large
variability in normal trichromacy. Our current results are
consistent with those of that report. A plastic neural
normalization mechanism may exist that allows the visual
system to use information to compensate for individual
differences in the cone ratio and make perception uniform.26
The M and S CCTs were correlated significantly with those
of the MD (P < 0.05). Quantifying acquired color vision
deficiencies using the Farnsworth-Munsell 100-hue test (100
hue FM), Flammer and Drance6 and Papaconstantinou et al.34
reported significant correlations between the total error score
of the 100-hue FM and the indices of the visual field tests in
eyes with glaucoma. However, 100-hue FM is not feasible for
routine clinical use. The RCCT enables us to measure
chromatic contrast threshold faster and more easily. The
measurement of chromatic contrast threshold using the RCCT
may be useful for monitoring glaucoma progression.
In the current study, the M and S CCTs were correlated
significantly (P < 0.01) with the GCIPL thickness. Glaucoma is
a disease caused by progressive retinal ganglion cell loss
associated with characteristic structural changes. Recent
advances in OCT techniques have allowed quantitative
measurement of individual retinal layers and their changes.
Several reports have found a qualitative correlation between
local loss in visual sensitivity and local thickness of the
GCIPL.35–38 However, these reports failed to evaluate chromat-
ic deficiency and used conventional white-on-white perimetry
to detect loss of visual function. No relationship has been
reported between structural changes detected by OCT and
chromatic deficiency in glaucoma. Our results may suggest a
correlation between anatomic abnormalities detected by OCT
and chromatic discrimination thresholds measured by RCCT.
However, we do not expect to find cone-specific sensitivity
loss in glaucoma because this disease has its greatest effect on
ganglion cells that transmit already-transformed color oppo-
nent signals; L and M cone isolating stimuli modulate not only
red-green and but also blue-yellow color opponent pathways.
In addition, L and M cone results reflect the relative inputs to
this blue-yellow pathway. The reason that the M CCTs have the
strongest correlation with the visual field indices and the
thickness of GCIPL is not well understood. Our results confirm
that color vision deficiency is acquired in glaucoma and may be
useful to clarify the pathophysiology of glaucomatous damage.
The current study had some limitations. First, we screened
for the presence of congenital color vision deficiency using
pseudoisochromatic plates. However, the only way to ensure
that color vision deficiency has a congenital cause is through
analysis of molecular genetics.39 Therefore, congenital color
vision deficiency might not be excluded strictly in this study.
Second, each step of the RCCT has been simplified to make the
test easier to administer. Cone contrast thresholds for normal
observers are usually at ceiling performance levels, making
correlation with subtle deficiencies difficult. Third, this was a
cross-sectional study, and we did not know whether low RCCT
scores can predict glaucomatous progression. Confirmatory
longitudinal studies are needed. Last, the number of current
patients was small. A study with more patients is warranted to
define more accurately the relationship between RCCT scores
and conventional perimetric measures of glaucomatous damage.
In conclusion, the chromatic discrimination thresholds
measured by RCCT in the glaucoma group were significantly
different from that measured in the control group and were
correlated with the MD and GCIPL thickness. The RCCT may
be useful for evaluating acquired color vision deficiency in
glaucoma and may help advance the current understanding of
the pathophysiology of glaucomatous damage.
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